On May 21, 2015, Vlahov, Iontcho R.; Leamon, Christopher P.; Low, Philip S.; Parham, Garth L.; Chen, Qingshou published a patent.Application of 53838-27-0 The title of the patent was Compounds for positron emission tomography. And the patent contained the following:
Described herein are compounds, compositions, and methods for diagnosing and/or monitoring pathogenic disease using positron emission tomog. Also described are conjugates of the formula B-L-P, wherein B is a radical of a targeting agent selected from vitamin receptor binding ligands (such as folate), PSMA binding ligands, or PSMA inhibitors; L is a divalent linker comprising aspartic acid, lysine, or arginine, and P is a radical of an imaging agent or radiotherapy agent, such as a radionuclide or radionuclide containing group, or a radical of a compound capable of binding a radionuclide, such as a metal chelating group. The experimental process involved the reaction of (S)-5-tert-Butyl 1-methyl 2-aminopentanedioate(cas: 53838-27-0).Application of 53838-27-0
The Article related to pet contrast agent conjugate, Radiation Biochemistry: Disease Diagnosis and Therapy and other aspects.Application of 53838-27-0
Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics